Active substances
Amino acids + Source unspecified
- SFDA 12
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AMINOVEN | 15 % | Solution for infusion · Intravenous use | 1 Bottle | SAR 54.80 | Generic · Prescription | FRESENIUS KABI | Valid |
| AMINOFUSIN L,10% W-O CARBOHYDRATE | 10 % | Solution · Intravenous use | 1 Bottle | SAR 68.65 | Generic · Prescription | PFRIMMER | Withdrawn by MAH · Not Marketed |
| AMINOFUSIN PAED 900 | Solution · Intravenous use | 1 Bottle | SAR 38.40 | Generic · Prescription | PFRIMMER | Withdrawn by MAH · Not Marketed | |
| AMINOSTERIL NEPHRO CARBOHYD FREE | Solution for infusion · Intravenous use | 1 Bottle | SAR 39.35 | Generic · Prescription | FRESENIUS KABI | Withdrawn by MAH · Not Marketed | |
| AMINOSYN 10% | 10 % | Solution for infusion · Intravenous use | 1 Bag | SAR 64.45 | Generic · Prescription | Abbott Laboratories | Withdrawn by MAH · Not Marketed |
| FREAMINE III | 8.5 % | Solution · Intravenous use | 1 Bottle | SAR 39.60 | Generic · Prescription | McGAW | Invalid · Not Marketed |
| HEPATAMINE | 8 % | Solution · Intravenous use | 1 Bottle | SAR 125.25 | Generic · Prescription | McGAW | Invalid · Not Marketed |
| TRAVASOL 10% INJECION | 10 % | Solution for infusion · Intravenous use | 1 Bag | SAR 57.00 | Generic · Prescription | BAXTER HEALTHCARE | Withdrawn by MAH · Not Marketed |
| TRAVASOL 10% INJECION | 10 % | Solution for infusion · Intravenous use | 1 Bag | SAR 96.45 | Generic · Prescription | BAXTER HEALTHCARE | Withdrawn by MAH · Not Marketed |
| TRAVASOL 10% INJECION | 10 % | Solution for infusion · Intravenous use | 1 Bag | SAR 36.55 | Generic · Prescription | BAXTER HEALTHCARE | Withdrawn by MAH · Not Marketed |
| VAMIN 14 (ELECTROLYTE-FREE) | 13.5 g/l | Solution for infusion · Intravenous use | 1 Blister | SAR 72.40 | Generic · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
| VAMIN 18 (ELECTROLYTE-FREE) | 18 g/l | Solution for infusion · Intravenous use | 1 Bottle | SAR 82.40 | Generic · Prescription | OCTAPHARMA | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE PANCREATITIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.